Palisade Capital Management

mobile
Home > News & Insight

News & Insight

At Palisade Capital Management, we think differently than other asset managers. We believe in sharing ideas and research across teams—and now with you. Here you can gain access to our vast intellectual capital and decidedly different perspective, while seeing what we’ve been up to lately.



Tuesday, April 14, 2015
Rising Rates and the Strong Dollar:      The Case for Small Cap Investing
Posted in White Papers
In April 2015, Chief Investment Officer Dennison "Dan" T. Veru released a white paper discussing the allocation of capital in a rising interest rate and strong dollar environment.

Download the White Paper

For further information regarding this white paper or about Palisade Capital Management, please contact us at info@palcap.com.
Wednesday, April 01, 2015
PCEP II Portfolio Company Brickell Biotech, Inc. Signs Exclusive License and Development Agreement for BBI-4000 with Kaken Pharmaceutical Co., Ltd.
Posted in Private Equity News
Brickell Biotech, Inc. (“Brickell”), a clinical-stage pharmaceutical company focused on the development of differentiated, innovative therapeutics to satisfy current unmet medical needs in the global dermatology markets, today announced the signing of an exclusive license and development agreement for BBI-4000 with Kaken Pharmaceutical Co., Ltd. (“Kaken”), a top-tier specialty pharmaceutical company in Japan with strong experience in developing and commercializing novel dermatological drugs.
Tuesday, February 03, 2015
PCEPII Portfolio Company Brickell Biotech Announces $10M Series C Financing, Initiates Phase 2b Study of BBI-4000 in Patients with Axillary Hyperhidrosis, and Acquires Novel, Clinical-Stage Compound for the Oral Treatment of Atopic Dermatitis
Posted in Private Equity News
Brickell Biotech, Inc. (“Brickell”), a clinical-stage pharmaceutical company focused on the development of differentiated, innovative therapeutics to satisfy current unmet medical needs in the global dermatology markets, today announced a $10 million Series C financing round (the “Offering”). Brickell’s pipeline includes new molecular entities in dermatology for hyperhidrosis, atopic dermatitis, and acne.
Monday, January 12, 2015
Q4 2014 Investor Commentary
Posted in Market Commentaries
As we write this letter, the stock market is experiencing one of its periodic swoons. Since the last day of 2014, the S&P 500® has dropped five of the last seven trading days. Market commentators are pinning much of the blame on the falling price of oil, which now hovers at $45 per barrel (West Texas intermediate grade oil quoted on the New York Mercantile Exchange). Oil has dropped 20 of the last 30 trading days since OPEC’s pivotal Vienna meeting on Thanksgiving Day (November 27). Suddenly analysts are saying, in a twist of Mae West’s famous aphorism, “Too much of a good thing may not be so wonderful after all.”
Read More
Wednesday, November 19, 2014
PPPII Portfolio Company QualityHealth Acquired by Sharecare
Posted in Private Equity News
Sharecare, a comprehensive health and wellness engagement platform, today announced the acquisition of QualityHealth, a platform for identifying patients at large scale, and activating them to take relevant health-specific actions. As one of the industry’s largest permission-based databases, QualityHealth has more than 50 million registered members and touches 100 million health consumers each month across 175 different health, wellness and therapeutic categories. PPPII will continue to own Sharecare equity post-closing.
Monday, October 13, 2014
Q3 2014 Investor Commentary
Posted in Market Commentaries
“Why are the financial markets so jittery?” Palisade Capital Management presents its analysis of recent stock market volatility and the economic factors which influence markets on a global level. Palisade poses the question: “When have there ever not been things to worry about?”
Read More
 1 2 3 >  Last ›
Latest Research and White Papers
Tuesday, April 14, 2015
Rising Rates and the Strong Dollar:      The Case for Small Cap Investing
In April 2015, Chief Investment Officer Dennison "Dan" T. Veru released a white paper discussing the allocation of capital in a rising interest rate and strong dollar environment.

Download the White Paper

For further information regarding this white paper or about Palisade Capital Management, please contact us at info@palcap.com.

See all Research and White Papers



Select A Category

Connect with Us

One Bridge Plaza, Suite 695, Fort Lee, New Jersey 07024 | (201) 585-7733 | (800) 330-9966 | Get Directions | Contact Us

Stay Informed

Sign up for our mailing list and stay up to date on the latest information and news from Palisade Capital Management.